NIAMS Clinical Trial Outcomes Instrument Development Grant Program (U01)

Post Date

April 17th 2009

Application Due Date

August 31st 2009

Funding Opportunity Number

RFA-AR-10-005

CFDA Number(s)

93.846

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Health

Eligibility Categories

State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Funding

• Estimated Total Funding:

  $1000000

• Award Range:

  $None - $150000

Grant Description

Purpose. This Funding Opportunity Announcement (FOA), issued by the NIAMS, National Institutes of Health, solicits applications for research awards designed to develop and evaluate new clinical trial outcomes measures to assess the adverse events, and the link between efficacy and effectiveness of therapies employed to treat diseases, illnesses and injuries of interest to the NIAMS. This FOA seeks to facilitate the development and initial evaluation of new clinically-relevant and patient-important outcome measures and instruments that could be further tested with existing or novel clinical trials designed to gain widespread acceptance and application in the diagnosis, treatment or cure of diseases, illnesses and injuries of interest to the NIAMS. Mechanism of Support. This FOA will utilize the U01 cooperative agreement grant mechanism. Funds Available and Anticipated Number of Awards. The NIAMS intends to commit approximately $1.0 million in FY 2010 to fund four or five new grants in response to this FOA. These awards are not renewable.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/rfa-files/RFA-AR-10-005.html